
RC Capital
Description
RC Capital, also known as River Cities Capital Funds, is a distinguished growth equity firm based in Cincinnati, United States, with a dedicated focus on the healthcare sector. The firm targets the lower end of the middle market, seeking to invest in innovative companies across healthcare services, healthcare IT, and medical devices/diagnostics. Their investment philosophy centers on providing growth capital to businesses that have demonstrated strong market traction and are poised for significant expansion, often partnering closely with management teams to accelerate their strategic objectives and operational excellence.
RC Capital's investment strategy is highly selective, targeting companies that typically generate between $10 million and $100 million in revenue and $2 million to $20 million in EBITDA. The firm is known for its substantial first checks, with a typical investment range from $10 million to $40 million per company. This significant capital infusion is designed to support various growth initiatives, including market expansion, product development, and strategic acquisitions, enabling portfolio companies to scale rapidly and capture larger market shares.
The firm has a long-standing history of successful fundraises, demonstrating consistent investor confidence. Their most recent fund, River Cities Capital Fund VII, closed in 2021 with $250 million in commitments, further solidifying their capacity to deploy substantial capital into promising healthcare ventures. This robust financial backing, combined with their deep industry expertise and extensive network, positions RC Capital as a key partner for growth-stage healthcare companies looking to navigate complex market dynamics and achieve long-term success.
Investor Profile
RC Capital has backed more than 102 startups, with 3 new investments in the last 12 months alone. The firm has led 47 rounds, about 46% of its total and boasts 49 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Japan.
- Strong thematic focus on Health Care, Software, Medical.
- Typical check size: $10M – $40M.
Stage Focus
- Series Unknown (34%)
- Series C (19%)
- Series B (19%)
- Series D (12%)
- Series A (8%)
- Private Equity (5%)
- Series E (2%)
- Series F (1%)
- Series G (1%)
Country Focus
- United States (98%)
- Japan (1%)
Industry Focus
- Health Care
- Software
- Medical
- Medical Device
- Biotechnology
- Saas
- Information Technology
- Internet
- Mobile
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.